calcitriol 0.25 mcg
INDICATIONS AND USAGE Predialysis Patients Calcitriol capsule is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥ 100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol capsule is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol capsule is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypopara-thyroidism.
avet pharmaceuticals inc.
OVAL ORANGE 673
Related Pills
calcitriol 0.25 mcg
avet pharmaceuticals inc.
Dextroamphetamine Sulfate 5 MG Extended Release Oral Capsule
amneal pharmaceuticals of new york llc
Spironolactone 100 MG Oral Tablet
Actavis Pharma, Inc.
nebivolol 10 mg
Solco Healthcare US, LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED capsules: 0.25 mcg
CALCITRIOL in soft gelatin, orange, oval capsules, imprinted with 673; bottles of 30 (NDC 23155-662-03), and bottles of 100 (NDC 23155-662-01). capsules : 0.5 mcg
CALCITRIOL in soft gelatin, orange, oblong capsules, imprinted with 674; bottles of 100 (NDC 23155-663-01).
CALCITRIOL capsules should be protected from light. Store at 20° to 25°C (68° to 77°C F) [See USP Controlled Room Temperature]
More pills like OVAL 673